{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:37:12Z","timestamp":1793659032372,"version":"4.5.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vestibular schwannoma (VS) is a Schwann cell-derived tumour arising from the vestibulocochlear nerve. Although benign, it represents a threat to intracranial structures due to mass effect and carries a small risk of malignant transformation. VS therefore represents an important healthcare burden. We review the literature regarding pathogenesis, risk factors, and diagnosis of VS. The current and future potential management strategies are also discussed. A narrative review of all relevant papers known to the authors was conducted. The majority of VS remain clinically stable and do not require interventional procedures. Nevertheless, various surgical techniques exist for removing VS, the most common of which are translabyrinthine and retrosigmoid approaches. Due to surgical risks such as hearing loss, facial nerve dysfunction, post-operative headache, and cerebrospinal fluid leakage, a \"watch and rescan\" approach is adopted for most patients. Radiotherapy is a useful alternative and has been shown to have a similar response for growth restriction. Due to the heterogeneous nature of VS, there is a lack of consensus regarding management of tumours that are too large for conservative management but too small to indicate surgery. Emerging biologic therapies, such as Bevacizumab, Everolimus, and Lapatinib, as well as anti-inflammatories like aspirin are promising potential treatments; however, long-term evidence of their efficacy is required. The knowledge base regarding VS continues to improve. With increased understanding of the pathogenesis of these tumors, we believe future work should focus on pharmacologic intervention. Biologic therapies aimed toward improved patient outcomes are particularly promising.<\/jats:p>","DOI":"10.1007\/s12105-020-01155-x","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:05:03Z","timestamp":1585595103000},"page":"1058-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["Vestibular Schwannoma: What We Know and Where We are Heading"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6139-4950","authenticated-orcid":false,"given":"Vinay Kumar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjuna","family":"Thakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"issue":"1","key":"1155_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12070-014-0736-0","volume":"67","author":"K Singh","year":"2015","unstructured":"Singh K, Singh MP, Thukral C, Rao K, Singh K, Singh A. Role of magnetic resonance imaging in evaluation of cerebellopontine angle schwannomas. Indian J Otolaryngol Head Neck Surg. 2015;67(1):21\u20137. https:\/\/doi.org\/10.1007\/s12070-014-0736-0.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"3","key":"1155_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3171\/jns.1998.88.3.0506","volume":"88","author":"WT Koos","year":"1998","unstructured":"Koos WT, Day JD, Matula C, Levy DI. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg. 1998;88(3):506\u201312. https:\/\/doi.org\/10.3171\/jns.1998.88.3.0506.","journal-title":"J Neurosurg"},{"issue":"5","key":"1155_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1055\/s-0029-1220205","volume":"19","author":"A Dublin","year":"2009","unstructured":"Dublin A. Acoustic neuroma or vestibular schwannoma? Skull Base. 2009;19(5):375. https:\/\/doi.org\/10.1055\/s-0029-1220205.","journal-title":"Skull Base"},{"issue":"1","key":"1155_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006123-199701000-00001","volume":"40","author":"C Matthies","year":"1997","unstructured":"Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1\u20139. https:\/\/doi.org\/10.1097\/00006123-199701000-00001(discussion-10).","journal-title":"Neurosurgery."},{"issue":"1","key":"1155_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005;26(1):93\u20137. https:\/\/doi.org\/10.1097\/00129492-200501000-00016.","journal-title":"Otol Neurotol"},{"key":"1155_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.envres.2018.06.043","volume":"167","author":"AB Miller","year":"2018","unstructured":"Miller AB, Morgan LL, Udasin I, Davis DL. Cancer epidemiology update, following the 2011 IARC evaluation of radiofrequency electromagnetic fields (Monograph 102). Environ Res. 2018;167:673\u201383. https:\/\/doi.org\/10.1016\/j.envres.2018.06.043.","journal-title":"Environ Res"},{"issue":"10","key":"1155_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/0003489418788385","volume":"127","author":"M Koo","year":"2018","unstructured":"Koo M, Lai JT, Yang EY, Liu TC, Hwang JH. Incidence of vestibular Schwannoma in Taiwan from 2001 to 2012: a population-based national health insurance study. Ann Otol Rhinol Laryngol. 2018;127(10):694\u20137. https:\/\/doi.org\/10.1177\/0003489418788385.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"1155_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1227\/NEU.0b013e3181f22660","volume":"67","author":"SE Stangerup","year":"2010","unstructured":"Stangerup SE, Tos M, Thomsen J, Caye-Thomasen P. True incidence of vestibular schwannoma? Neurosurgery. 2010;67(5):1335\u2013400. https:\/\/doi.org\/10.1227\/NEU.0b013e3181f22660(discussion 40).","journal-title":"Neurosurgery."},{"issue":"2","key":"1155_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0022215107001028","volume":"122","author":"T Khrais","year":"2008","unstructured":"Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2008;122(2):128\u201331. https:\/\/doi.org\/10.1017\/S0022215107001028.","journal-title":"J Laryngol Otol"},{"issue":"4","key":"1155_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3325\/cmj.2012.53.321","volume":"53","author":"N Pecina-Slaus","year":"2012","unstructured":"Pecina-Slaus N, Zeljko M, Pecina HI, Nikuseva Martic T, Bacic N, Tomas D, et al. Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients. Croat Med J. 2012;53(4):321\u20137. https:\/\/doi.org\/10.3325\/cmj.2012.53.321.","journal-title":"Croat Med J"},{"issue":"11","key":"1155_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/jmg.40.11.802","volume":"40","author":"C Warren","year":"2003","unstructured":"Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, et al. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet. 2003;40(11):802\u20136. https:\/\/doi.org\/10.1136\/jmg.40.11.802.","journal-title":"J Med Genet"},{"issue":"5","key":"1155_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00106-016-0201-3","volume":"65","author":"M Brodhun","year":"2017","unstructured":"Brodhun M, Stahn V, Harder A. Pathogenesis and molecular pathology of vestibular schwannoma. HNO. 2017;65(5):362\u201372. https:\/\/doi.org\/10.1007\/s00106-016-0201-3.","journal-title":"HNO"},{"issue":"6","key":"1155_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3171\/2015.11.JNS151766","volume":"125","author":"GU Mehta","year":"2016","unstructured":"Mehta GU, Feldman MJ, Wang H, Ding D, Chittiboina P. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation. J Neurosurg. 2016;125(6):1469\u201371. https:\/\/doi.org\/10.3171\/2015.11.JNS151766.","journal-title":"J Neurosurg"},{"issue":"19","key":"1155_CR14","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1038\/sj.onc.1210923","volume":"27","author":"C Thaxton","year":"2008","unstructured":"Thaxton C, Lopera J, Bott M, Fernandez-Valle C. Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways. Oncogene. 2008;27(19):2705\u201315. https:\/\/doi.org\/10.1038\/sj.onc.1210923.","journal-title":"Oncogene"},{"issue":"5","key":"1155_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/glia.20629","volume":"56","author":"C Flaiz","year":"2008","unstructured":"Flaiz C, Utermark T, Parkinson DB, Poetsch A, Hanemann CO. Impaired intercellular adhesion and immature adherens junctions in merlin-deficient human primary schwannoma cells. Glia. 2008;56(5):506\u201315. https:\/\/doi.org\/10.1002\/glia.20629.","journal-title":"Glia"},{"issue":"6","key":"1155_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1086\/301633","volume":"61","author":"LB Jacoby","year":"1997","unstructured":"Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, et al. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet. 1997;61(6):1293\u2013302. https:\/\/doi.org\/10.1086\/301633.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1155_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3171\/2016.10.JNS161384","volume":"128","author":"AL Havik","year":"2018","unstructured":"Havik AL, Bruland O, Myrseth E, Miletic H, Aarhus M, Knappskog PM, et al. Genetic landscape of sporadic vestibular schwannoma. J Neurosurg. 2018;128(3):911\u201322. https:\/\/doi.org\/10.3171\/2016.10.JNS161384.","journal-title":"J Neurosurg"},{"issue":"4","key":"1155_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/neuonc\/nou317","volume":"17","author":"R Dewan","year":"2015","unstructured":"Dewan R, Pemov A, Kim HJ, Morgan KL, Vasquez RA, Chittiboina P, et al. Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas. Neuro Oncol. 2015;17(4):566\u201373. https:\/\/doi.org\/10.1093\/neuonc\/nou317.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1155_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1215\/15228517-2007-047","volume":"10","author":"AB Schneider","year":"2008","unstructured":"Schneider AB, Ron E, Lubin J, Stovall M, Shore-Freedman E, Tolentino J, et al. Acoustic neuromas following childhood radiation treatment for benign conditions of the head and neck. Neuro Oncol. 2008;10(1):73\u20138. https:\/\/doi.org\/10.1215\/15228517-2007-047.","journal-title":"Neuro Oncol"},{"issue":"20","key":"1155_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/jnci\/94.20.1555","volume":"94","author":"DL Preston","year":"2002","unstructured":"Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst. 2002;94(20):1555\u2013633. https:\/\/doi.org\/10.1093\/jnci\/94.20.1555.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1155_CR21","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/cncr.20543","volume":"101","author":"S Yonehara","year":"2004","unstructured":"Yonehara S, Brenner AV, Kishikawa M, Inskip PD, Preston DL, Ron E, et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958\u20131995. Cancer. 2004;101(7):1644\u201354. https:\/\/doi.org\/10.1002\/cncr.20543.","journal-title":"Cancer"},{"issue":"13","key":"1155_CR22","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.ejca.2007.06.020","volume":"43","author":"M Blettner","year":"2007","unstructured":"Blettner M, Schlehofer B, Samkange-Zeeb F, Berg G, Schlaefer K, Schuz J. Medical exposure to ionising radiation and the risk of brain tumours: interphone study group. Germany Eur J Cancer. 2007;43(13):1990\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2007.06.020.","journal-title":"Germany Eur J Cancer"},{"issue":"3","key":"1155_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/aje\/kwh032","volume":"159","author":"HC Christensen","year":"2004","unstructured":"Christensen HC, Schuz J, Kosteljanetz M, Poulsen HS, Thomsen J, Johansen C. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol. 2004;159(3):277\u201383. https:\/\/doi.org\/10.1093\/aje\/kwh032.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1155_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/EDE.0b013e3181b0927d","volume":"20","author":"A Ahlbom","year":"2009","unstructured":"Ahlbom A, Feychting M, Green A, Kheifets L, Savitz DA, Swerdlow AJ, et al. Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology. 2009;20(5):639\u201352. https:\/\/doi.org\/10.1097\/EDE.0b013e3181b0927d.","journal-title":"Epidemiology"},{"issue":"12","key":"1155_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/oem.2006.028308","volume":"63","author":"T Takebayashi","year":"2006","unstructured":"Takebayashi T, Akiba S, Kikuchi Y, Taki M, Wake K, Watanabe S, et al. Mobile phone use and acoustic neuroma risk in Japan. Occup Environ Med. 2006;63(12):802\u20137. https:\/\/doi.org\/10.1136\/oem.2006.028308.","journal-title":"Occup Environ Med"},{"issue":"2\u20133","key":"1155_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pathophys.2009.01.003","volume":"16","author":"L Hardell","year":"2009","unstructured":"Hardell L, Carlberg M, Hansson MK. Epidemiological evidence for an association between use of wireless phones and tumor diseases. Pathophysiology. 2009;16(2\u20133):113\u201322. https:\/\/doi.org\/10.1016\/j.pathophys.2009.01.003.","journal-title":"Pathophysiology"},{"issue":"2","key":"1155_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pathophys.2012.11.001","volume":"20","author":"L Hardell","year":"2013","unstructured":"Hardell L, Carlberg M, Hansson MK. Use of mobile phones and cordless phones is associated with increased risk for glioma and acoustic neuroma. Pathophysiology. 2013;20(2):85\u2013110. https:\/\/doi.org\/10.1016\/j.pathophys.2012.11.001.","journal-title":"Pathophysiology"},{"issue":"5","key":"1155_CR28","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3892\/ijo.2015.2908","volume":"46","author":"LL Morgan","year":"2015","unstructured":"Morgan LL, Miller AB, Sasco A, Davis DL. Mobile phone radiation causes brain tumors and should be classified as a probable human carcinogen (2A) (review). Int J Oncol. 2015;46(5):1865\u201371. https:\/\/doi.org\/10.3892\/ijo.2015.2908.","journal-title":"Int J Oncol"},{"issue":"6","key":"1155_CR29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.wneu.2015.07.007","volume":"84","author":"O Berkowitz","year":"2015","unstructured":"Berkowitz O, Iyer AK, Kano H, Talbott EO, Lunsford LD. Epidemiology and environmental risk factors associated with vestibular Schwannoma. World Neurosurg. 2015;84(6):1674\u201380. https:\/\/doi.org\/10.1016\/j.wneu.2015.07.007.","journal-title":"World Neurosurg"},{"issue":"1","key":"1155_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14737175.2018.1399795","volume":"18","author":"J Halliday","year":"2018","unstructured":"Halliday J, Rutherford SA, McCabe MG, Evans DG. An update on the diagnosis and treatment of vestibular schwannoma. Expert Rev Neurother. 2018;18(1):29\u201339. https:\/\/doi.org\/10.1080\/14737175.2018.1399795.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"1155_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1017\/s0022215100144391","volume":"113","author":"JP Harcourt","year":"1999","unstructured":"Harcourt JP, Vijaya-Sekaran S, Loney E, Lennox P. The incidence of symptoms consistent with cerebellopontine angle lesions in a general ENT out-patient clinic. J Laryngol Otol. 1999;113(6):518\u201322. https:\/\/doi.org\/10.1017\/s0022215100144391.","journal-title":"J Laryngol Otol"},{"issue":"2","key":"1155_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archotol.125.2.232","volume":"125","author":"KJ Doyle","year":"1999","unstructured":"Doyle KJ. Is there still a role for auditory brainstem response audiometry in the diagnosis of acoustic neuroma? Arch Otolaryngol Head Neck Surg. 1999;125(2):232\u20134. https:\/\/doi.org\/10.1001\/archotol.125.2.232.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1155_CR33","unstructured":"NICE. Tinnitus. 2017. https:\/\/cks.nice.org.uk\/tinnitus\u2014!topicSummary."},{"key":"1155_CR34","doi-asserted-by":"publisher","unstructured":"Fortnum H, O'Neill C, Taylor R, Lenthall R, Nikolopoulos T, Lightfoot G et al. The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history. Health Technol Assess. 2009;13(18):iii-iv, ix-xi, 1\u2013154https:\/\/doi.org\/10.3310\/hta13180.","DOI":"10.3310\/hta13180"},{"issue":"3","key":"1155_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MAO.0b013e3181d279a3","volume":"31","author":"TP Nikolopoulos","year":"2010","unstructured":"Nikolopoulos TP, Fortnum H, O'Donoghue G, Baguley D. Acoustic neuroma growth: a systematic review of the evidence. Otol Neurotol. 2010;31(3):478\u201385. https:\/\/doi.org\/10.1097\/MAO.0b013e3181d279a3.","journal-title":"Otol Neurotol"},{"issue":"3","key":"1155_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/S0022215109992362","volume":"124","author":"R Suryanarayanan","year":"2010","unstructured":"Suryanarayanan R, Ramsden RT, Saeed SR, Aggarwal R, King AT, Rutherford SA, et al. Vestibular schwannoma: role of conservative management. J Laryngol Otol. 2010;124(3):251\u20137. https:\/\/doi.org\/10.1017\/S0022215109992362.","journal-title":"J Laryngol Otol"},{"key":"1155_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/00016489109130462","volume":"487","author":"K Ogawa","year":"1991","unstructured":"Ogawa K, Kanzaki J, Ogawa S, Yamamoto M, Ikeda S, Shiobara R. The growth rate of acoustic neuromas. Acta Otolaryngol Suppl. 1991;487:157\u201363. https:\/\/doi.org\/10.3109\/00016489109130462.","journal-title":"Acta Otolaryngol Suppl"},{"issue":"6","key":"1155_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1258\/0022215054273089","volume":"119","author":"D Flint","year":"2005","unstructured":"Flint D, Fagan P, Panarese A. Conservative management of sporadic unilateral acoustic neuromas. J Laryngol Otol. 2005;119(6):424\u20138. https:\/\/doi.org\/10.1258\/0022215054273089.","journal-title":"J Laryngol Otol"},{"issue":"3","key":"1155_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/mao.0b013e31819a8df6","volume":"30","author":"TP Martin","year":"2009","unstructured":"Martin TP, Senthil L, Chavda SV, Walsh R, Irving RM. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol. 2009;30(3):381\u20135. https:\/\/doi.org\/10.1097\/mao.0b013e31819a8df6.","journal-title":"Otol Neurotol"},{"issue":"3","key":"1155_CR40","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2012.6.FOCUS12163","volume":"33","author":"SF Ansari","year":"2012","unstructured":"Ansari SF, Terry C, Cohen-Gadol AA. Surgery for vestibular schwannomas: a systematic review of complications by approach. Neurosurg Focus. 2012;33(3):E14. https:\/\/doi.org\/10.3171\/2012.6.FOCUS12163.","journal-title":"Neurosurg Focus"},{"issue":"5","key":"1155_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3171\/jns.1998.88.5.0840","volume":"88","author":"RM Irving","year":"1998","unstructured":"Irving RM, Jackler RK, Pitts LH. Hearing preservation in patients undergoing vestibular schwannoma surgery: comparison of middle fossa and retrosigmoid approaches. J Neurosurg. 1998;88(5):840\u20135. https:\/\/doi.org\/10.3171\/jns.1998.88.5.0840.","journal-title":"J Neurosurg"},{"issue":"9","key":"1155_CR42","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1097\/MLG.0b013e3180caa162","volume":"117","author":"SA Douglas","year":"2007","unstructured":"Douglas SA, Yeung P, Daudia A, Gatehouse S, O'Donoghue GM. Spatial hearing disability after acoustic neuroma removal. Laryngoscope. 2007;117(9):1648\u201351. https:\/\/doi.org\/10.1097\/MLG.0b013e3180caa162.","journal-title":"Laryngoscope"},{"key":"1155_CR43","doi-asserted-by":"publisher","first-page":"Doc05","DOI":"10.3205\/cto000097","volume":"12","author":"B Schick","year":"2013","unstructured":"Schick B, Dlugaiczyk J. Surgery of the ear and the lateral skull base: pitfalls and complications. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013;12:Doc05. https:\/\/doi.org\/10.3205\/cto000097.","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg."},{"issue":"6","key":"1155_CR44","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/mao.0b013e31811f40ad","volume":"28","author":"D Tufarelli","year":"2007","unstructured":"Tufarelli D, Meli A, Labini FS, Badaracco C, De Angelis E, Alesii A, et al. Balance impairment after acoustic neuroma surgery. Otol Neurotol. 2007;28(6):814\u201321. https:\/\/doi.org\/10.1097\/mao.0b013e31811f40ad.","journal-title":"Otol Neurotol"},{"issue":"10","key":"1155_CR45","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1468-2982.2007.01410.x","volume":"27","author":"T Rimaaja","year":"2007","unstructured":"Rimaaja T, Haanpaa M, Blomstedt G, Farkkila M. Headaches after acoustic neuroma surgery. Cephalalgia. 2007;27(10):1128\u201335. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01410.x.","journal-title":"Cephalalgia"},{"issue":"2","key":"1155_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11060-010-0315-5","volume":"102","author":"O Bloch","year":"2011","unstructured":"Bloch O, Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, et al. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol. 2011;102(2):281\u20136. https:\/\/doi.org\/10.1007\/s11060-010-0315-5.","journal-title":"J Neurooncol"},{"issue":"9","key":"1155_CR47","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/MAO.0b013e318232e4a4","volume":"32","author":"BD Mangus","year":"2011","unstructured":"Mangus BD, Rivas A, Yoo MJ, Alvarez J, Wanna GB, Haynes DS, et al. Management of cerebrospinal fluid leaks after vestibular schwannoma surgery. Otol Neurotol. 2011;32(9):1525\u20139. https:\/\/doi.org\/10.1097\/MAO.0b013e318232e4a4.","journal-title":"Otol Neurotol"},{"issue":"2","key":"1155_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3171\/2009.10.JNS091203","volume":"114","author":"ME Sughrue","year":"2011","unstructured":"Sughrue ME, Yang I, Aranda D, Rutkowski MJ, Fang S, Cheung SW, et al. Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg. 2011;114(2):367\u201374. https:\/\/doi.org\/10.3171\/2009.10.JNS091203.","journal-title":"J Neurosurg"},{"issue":"2","key":"1155_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1288\/00005537-198902000-00010","volume":"99","author":"DA Wiegand","year":"1989","unstructured":"Wiegand DA, Fickel V. Acoustic neuroma\u2013the patient's perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope. 1989;99(2):179\u201387. https:\/\/doi.org\/10.1288\/00005537-198902000-00010.","journal-title":"Laryngoscope"},{"issue":"3","key":"1155_CR50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1227\/01.neu.0000079369.59219.c0","volume":"53","author":"DC Weber","year":"2003","unstructured":"Weber DC, Chan AW, Bussiere MR, Harsh GRT, Ancukiewicz M, Barker FG 2nd, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery. 2003;53(3):577\u201386. https:\/\/doi.org\/10.1227\/01.neu.0000079369.59219.c0(discussion 86-8).","journal-title":"Neurosurgery"},{"issue":"1","key":"1155_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijrobp.2009.01.064","volume":"76","author":"SE Combs","year":"2010","unstructured":"Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2010;76(1):193\u2013200. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.01.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1155_CR52","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","volume":"59","author":"TM Pawlik","year":"2004","unstructured":"Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59(4):928\u201342. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1155_CR53","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00701-017-3164-6","volume":"159","author":"O Persson","year":"2017","unstructured":"Persson O, Bartek J Jr, Shalom NB, Wangerid T, Jakola AS, Forander P. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir (Wien). 2017;159(6):1013\u201321. https:\/\/doi.org\/10.1007\/s00701-017-3164-6.","journal-title":"Acta Neurochir (Wien)."},{"issue":"1","key":"1155_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1227\/01.neu.0000163091.12239.bb","volume":"57","author":"AW Chan","year":"2005","unstructured":"Chan AW, Black P, Ojemann RG, Barker FG 2nd, Kooy HM, Lopes VV, et al. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery. 2005;57(1):60\u201370. https:\/\/doi.org\/10.1227\/01.neu.0000163091.12239.bb(discussion 60-70).","journal-title":"Neurosurgery."},{"issue":"3","key":"1155_CR55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.radonc.2015.01.011","volume":"114","author":"SE Combs","year":"2015","unstructured":"Combs SE, Engelhard C, Kopp C, Wiedenmann N, Schramm O, Prokic V, et al. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas\u2014pooled results from 3 large German centers. Radiother Oncol. 2015;114(3):378\u201383. https:\/\/doi.org\/10.1016\/j.radonc.2015.01.011.","journal-title":"Radiother Oncol"},{"issue":"3","key":"1155_CR56","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3171\/2012.10.JNS12523","volume":"118","author":"T Hasegawa","year":"2013","unstructured":"Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T. Long-term safety and efficacy of stereotactic radiosurgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg. 2013;118(3):557\u201365. https:\/\/doi.org\/10.3171\/2012.10.JNS12523.","journal-title":"J Neurosurg"},{"issue":"5","key":"1155_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1055\/s-2005-916493","volume":"56","author":"E Myrseth","year":"2005","unstructured":"Myrseth E, Moller P, Pedersen PH, Vassbotn FS, Wentzel-Larsen T, Lund-Johansen M. Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery. 2005;56(5):927\u201335. https:\/\/doi.org\/10.1055\/s-2005-916493(discussion-35).","journal-title":"Neurosurgery."},{"issue":"1","key":"1155_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1227\/01.NEU.0000219217.14930.14","volume":"59","author":"BE Pollock","year":"2006","unstructured":"Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59(1):77\u201385. https:\/\/doi.org\/10.1227\/01.NEU.0000219217.14930.14(discussion 77-85).","journal-title":"Neurosurgery."},{"issue":"Suppl","key":"1155_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3171\/2012.7.GKS12783","volume":"117","author":"S Sun","year":"2012","unstructured":"Sun S, Liu A. Long-term follow-up studies of Gamma Knife surgery with a low margin dose for vestibular schwannoma. J Neurosurg. 2012;117(Suppl):57\u201362. https:\/\/doi.org\/10.3171\/2012.7.GKS12783.","journal-title":"J Neurosurg"},{"issue":"4","key":"1155_CR60","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1227\/01.NEU.0000340684.60443.55","volume":"64","author":"E Myrseth","year":"2009","unstructured":"Myrseth E, Moller P, Pedersen PH, Lund-Johansen M. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery. 2009;64(4):654\u201361. https:\/\/doi.org\/10.1227\/01.NEU.0000340684.60443.55(discussion 61-3).","journal-title":"Neurosurgery."},{"key":"1155_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001345","author":"JG Wolbers","year":"2013","unstructured":"Wolbers JG, Dallenga AH, Mendez Romero A, van Linge A. What intervention is best practice for vestibular schwannomas? A systematic review of controlled studies. BMJ Open. 2013. https:\/\/doi.org\/10.1136\/bmjopen-2012-001345.","journal-title":"BMJ Open."},{"key":"1155_CR62","doi-asserted-by":"publisher","first-page":"CD009897","DOI":"10.1002\/14651858.CD009897.pub2","volume":"12","author":"D Muzevic","year":"2014","unstructured":"Muzevic D, Legcevic J, Splavski B, Caye-Thomasen P. Stereotactic radiotherapy for vestibular schwannoma. Cochrane Database Syst Rev. 2014;12:CD009897. https:\/\/doi.org\/10.1002\/14651858.CD009897.pub2.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"1155_CR63","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jocn.2008.09.023","volume":"16","author":"I Yang","year":"2009","unstructured":"Yang I, Aranda D, Han SJ, Chennupati S, Sughrue ME, Cheung SW, et al. Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci. 2009;16(6):742\u20137.","journal-title":"J Clin Neurosci"},{"key":"1155_CR64","doi-asserted-by":"publisher","DOI":"10.3171\/2017.8.JNS171281","author":"JM Frischer","year":"2018","unstructured":"Frischer JM, Gruber E, Schoffmann V, Ertl A, Hoftberger R, Mallouhi A, et al. Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study. J Neurosurg. 2018. https:\/\/doi.org\/10.3171\/2017.8.JNS171281.","journal-title":"J Neurosurg."},{"issue":"1","key":"1155_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00405-018-5199-6","volume":"276","author":"M Hentschel","year":"2019","unstructured":"Hentschel M, Rovers M, Markodimitraki L, Steens S, Kunst H. An international comparison of diagnostic and management strategies for vestibular schwannoma. Eur Arch Otorhinolaryngol. 2019;276(1):71\u20138. https:\/\/doi.org\/10.1007\/s00405-018-5199-6.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"11","key":"1155_CR66","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","volume":"28","author":"T Shih","year":"2006","unstructured":"Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther. 2006;28(11):1779\u2013802. https:\/\/doi.org\/10.1016\/j.clinthera.2006.11.015.","journal-title":"Clin Ther"},{"issue":"4","key":"1155_CR67","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med. 2009;361(4):358\u201367. https:\/\/doi.org\/10.1056\/NEJMoa0902579.","journal-title":"N Engl J Med"},{"issue":"6","key":"1155_CR68","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","volume":"33","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, et al. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol. 2012;33(6):1046\u201352. https:\/\/doi.org\/10.1097\/MAO.0b013e31825e73f5.","journal-title":"Otol Neurotol"},{"issue":"2","key":"1155_CR69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-019-03234-8","volume":"144","author":"VM Lu","year":"2019","unstructured":"Lu VM, Ravindran K, Graffeo CS, Perry A, Van Gompel JJ, Daniels DJ, et al. Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes. J Neurooncol. 2019;144(2):239\u201348. https:\/\/doi.org\/10.1007\/s11060-019-03234-8.","journal-title":"J Neurooncol"},{"issue":"4","key":"1155_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/nop\/npv065","volume":"3","author":"KA Morris","year":"2016","unstructured":"Morris KA, Golding JF, Axon PR, Afridi S, Blesing C, Ferner RE, et al. Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation. Neurooncol Pract. 2016;3(4):281\u20139. https:\/\/doi.org\/10.1093\/nop\/npv065.","journal-title":"Neurooncol Pract"},{"key":"1155_CR71","unstructured":"England N. 2013\/14 NHS Standard Contract for Neurofibromatosis Type 2 Service (All ages) 2013. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/06\/b13-neurofib-2.pdf."},{"issue":"1","key":"1155_CR72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11060-016-2276-9","volume":"131","author":"KA Morris","year":"2017","unstructured":"Morris KA, Golding JF, Blesing C, Evans DG, Ferner RE, Foweraker K, et al. Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort. J Neurooncol. 2017;131(1):117\u201324. https:\/\/doi.org\/10.1007\/s11060-016-2276-9.","journal-title":"J Neurooncol"},{"issue":"2","key":"1155_CR73","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1093\/neuros\/nyx516","volume":"82","author":"JJ Van Gompel","year":"2018","unstructured":"Van Gompel JJ, Agazzi S, Carlson ML, Adewumi DA, Hadjipanayis CG, Uhm JH, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on emerging therapies for the treatment of patients with vestibular Schwannomas. Neurosurgery. 2018;82(2):E52\u2013E5454. https:\/\/doi.org\/10.1093\/neuros\/nyx516.","journal-title":"Neurosurgery"},{"issue":"15","key":"1155_CR74","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","volume":"29","author":"MF James","year":"2009","unstructured":"James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, et al. NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol. 2009;29(15):4250\u201361. https:\/\/doi.org\/10.1128\/MCB.01581-08.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1155_CR75","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","volume":"15","author":"HA Lane","year":"2009","unstructured":"Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, et al. mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Clin Cancer Res. 2009;15(5):1612\u201322. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2057.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1155_CR76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/neuonc\/not150","volume":"16","author":"MA Karajannis","year":"2014","unstructured":"Karajannis MA, Legault G, Hagiwara M, Giancotti FG, Filatov A, Derman A, et al. Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol. 2014;16(2):292\u20137. https:\/\/doi.org\/10.1093\/neuonc\/not150.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1155_CR77","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-014-1710-0","volume":"122","author":"S Goutagny","year":"2015","unstructured":"Goutagny S, Raymond E, Esposito-Farese M, Trunet S, Mawrin C, Bernardeschi D, et al. Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. J Neurooncol. 2015;122(2):313\u201320. https:\/\/doi.org\/10.1007\/s11060-014-1710-0.","journal-title":"J Neurooncol"},{"issue":"8","key":"1155_CR78","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/neuonc\/noq012","volume":"12","author":"S Ammoun","year":"2010","unstructured":"Ammoun S, Cunliffe CH, Allen JC, Chiriboga L, Giancotti FG, Zagzag D, et al. ErbB\/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol. 2010;12(8):834\u201343. https:\/\/doi.org\/10.1093\/neuonc\/noq012.","journal-title":"Neuro Oncol"},{"issue":"9","key":"1155_CR79","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","volume":"14","author":"MA Karajannis","year":"2012","unstructured":"Karajannis MA, Legault G, Hagiwara M, Ballas MS, Brown K, Nusbaum AO, et al. Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol. 2012;14(9):1163\u201370. https:\/\/doi.org\/10.1093\/neuonc\/nos146.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1155_CR80","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1227\/NEU.0b013e318208f5c7","volume":"68","author":"B Hong","year":"2011","unstructured":"Hong B, Krusche CA, Schwabe K, Friedrich S, Klein R, Krauss JK, et al. Cyclooxygenase-2 supports tumor proliferation in vestibular schwannomas. Neurosurgery. 2011;68(4):1112\u20137. https:\/\/doi.org\/10.1227\/NEU.0b013e318208f5c7.","journal-title":"Neurosurgery"},{"issue":"1","key":"1155_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2014.12.007","volume":"166","author":"S Dilwali","year":"2015","unstructured":"Dilwali S, Kao SY, Fujita T, Landegger LD, Stankovic KM. Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res. 2015;166(1):1\u201311. https:\/\/doi.org\/10.1016\/j.trsl.2014.12.007.","journal-title":"Transl Res"},{"issue":"9","key":"1155_CR82","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/MAO.0000000000001180","volume":"37","author":"CK Kandathil","year":"2016","unstructured":"Kandathil CK, Cunnane ME, McKenna MJ, Curtin HD, Stankovic KM. Correlation between aspirin intake and reduced growth of human vestibular schwannoma: volumetric analysis. Otol Neurotol. 2016;37(9):1428\u201334. https:\/\/doi.org\/10.1097\/MAO.0000000000001180.","journal-title":"Otol Neurotol"},{"issue":"8","key":"1155_CR83","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/MAO.0000000000001506","volume":"38","author":"JB Hunter","year":"2017","unstructured":"Hunter JB, O'Connell BP, Wanna GB, Bennett ML, Rivas A, Thompson RC, et al. Vestibular Schwannoma growth with aspirin and other nonsteroidal anti-inflammatory drugs. Otol Neurotol. 2017;38(8):1158\u201364. https:\/\/doi.org\/10.1097\/MAO.0000000000001506.","journal-title":"Otol Neurotol"},{"issue":"9","key":"1155_CR84","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/lary.27114","volume":"128","author":"S MacKeith","year":"2018","unstructured":"MacKeith S, Wasson J, Baker C, Guilfoyle M, John D, Donnelly N, et al. Aspirin does not prevent growth of vestibular Schwannomas: a case-control study. Laryngoscope. 2018;128(9):2139\u201344. https:\/\/doi.org\/10.1002\/lary.27114.","journal-title":"Laryngoscope"},{"issue":"1","key":"1155_CR85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40478-019-0760-0","volume":"7","author":"F Behling","year":"2019","unstructured":"Behling F, Ries V, Skardelly M, Gepfner-Tuma I, Schuhmann M, Ebner FH, et al. COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake. Acta Neuropathol Commun. 2019;7(1):105. https:\/\/doi.org\/10.1186\/s40478-019-0760-0.","journal-title":"Acta Neuropathol Commun"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-020-01155-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:51:55Z","timestamp":1617061915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-020-01155-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1007\/s12105-020-01155-x","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}